Embody
Is this your company? Claim this profile.
Embody is a GLP-1 clinic. We found no FDA, OIG, or DEA actions in the records we checked. Pricing was not publicly listed, so total cost should be confirmed before signing up.
What they offerGLP-1 Clinic
Why this score?
The Vial Score measures how much of this provider's public record Vial could confirm, and how clearly the provider discloses it. It does not measure quality of care.
| 85-100 | High Confidence |
| 70-84 | Well Documented |
| 50-69 | Limited Confidence |
| 0-49 | Flagged |
Embody scores 50, in the Limited Confidence band. The score moves when the public record changes. For Embody, the item most likely to move it: Pricing.
Payment never changes a score.
2 of 4 checks complete. The remaining checks have not been run yet. Missing checks reduce how complete the profile is. They are not a finding by themselves.
Score history
50 since August 2026. Last checked September 1, 2026.
What we found on Embody
We reviewed FDA enforcement records, OIG exclusions, DEA registration, and HIPAA breach records.
Embody is a telehealth platform offering personalized GLP-1 weight loss treatment through remote consultations with clinicians. The service provides weekly injectable medications shipped directly to patients, starting at $79/month, with no membership fees or hidden costs. Treatment includes an initial assessment, personalized care plans, and ongoing clinician support.
Embody has no FDA, OIG, or DEA actions in the records we checked. We did not find public pricing, and the pharmacy relationship should be confirmed directly.
The main gap is pricing: we could not confirm the all-in monthly cost from public information. Before signing up, ask about medication cost, consult fees, shipping, cancellation terms, and which pharmacy fills the prescription.
Why this score: 2 of 4 checks complete. Each links to the public source it was verified against.
A check we haven’t completed yet is not a mark against this provider. It just means we’re still sourcing that record. The score reflects what we’ve confirmed so far, and updates as more checks come in.
Vial describes the record, not the provider. This is not a medical recommendation or endorsement. Last reviewed September 1, 2026.
Our take
Vial EditorialBased on the records and public materials we reviewed.
Stands out
Questions we’d want answered
Worth asking before you choose
Ask these before you sign up.
- 1Which pharmacy fills the prescription?Pharmacy
- 2What is the total monthly cost, including consults, medication, labs, and shipping?Cost
- 3Who prescribes the medication, and are they licensed in my state?Physician
- 4What happens if I cancel or stop treatment?Cancellation
Screenshot these or show your doctor: they’re the same questions Vial would ask.
Compare record details
Embody has no federal action found; AltRX has an FDA warning letter with no close-out letter found.
Embody scores 50, AltRX scores 38.
AltRX holds LegitScript certification; Embody does not.
| Embody | AltRX | |
|---|---|---|
| Federal actions | None found | Confirmed |
| Vial Score | 50/100 | 38/100 |
| LegitScript certified | No | Yes |
| States served | Not checked | Nationwide (50 states) |
What Vial measures, and what we don’t
We evaluate public records: federal enforcement history, registrations, certifications, and how transparent a provider is about its clinicians, pharmacies, and pricing. We don’t score bedside manner, clinical outcomes, or customer satisfaction, and we don’t collect user reviews.
Other GLP-1 providers in Vial
Other GLP-1 clinics in Vial’s directory. Open a profile, or compare side by side.
See 2 more alternativesShow fewer
Not sure where to start?Answer a few questions and we’ll narrow the directory to providers that fit.
Find your providerThis page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.